637. Myelodysplastic Syndromes—Clinical Studies: Personalized Clinical-Decision Tools and treatment of lower risk MDS
Watch Session
536 Phase 3 Study of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent (TD) Low Risk Del(5q) MDS Patients - Interim Analysis of the European Sintra-REV Trial clinically relevant abstract
Félix López Cadenas, Eva Lumbreras, Blanca Xicoy, et al. and Maria Diez-Campelo
Soo Park, Brian M Reilly, Timothy Luger, et al.
Constance Baer, Anna Stengel, Wolfgang Kern, Claudia Haferlach, and Torsten Haferlach.
Lin-Pierre Zhao, Maxime Boy, Celia Azoulay, et al.
Johannes B Goll, Travis L Jensen, R. Coleman Lindsley, et al.
Nathan Radakovich, Manja Meggendorfer, Luca Malcovati, et al.